ThursdayOct 11, 2018 10:12 am

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Well Placed for Metal Discoveries in South America’s Lithium Triangle

Assay work underway to complete five-hole exploration project at Chile’s northeastern border Assay of first Lithium Chile exploratory hole has returned results rivaling other companies’ projects in neighboring Argentina Lithium Chile holds one of the largest lithium land holdings in a country that has about 50 percent of the world’s reserves After securing one of the largest lithium land holdings in one of the largest lithium-producing nations on Earth, mineral explorer Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) is expecting good news resulting from its drilling program near Chile’s northeastern border with Bolivia. The region known widely as the ‘Lithium…

Continue Reading

ThursdayOct 11, 2018 10:10 am

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Posts Corporate Video Featuring its Refinery

Vertically integrated North American pure-play cobalt company First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) this morning released a corporate video highlighting the First Cobalt Refinery in Ontario, Canada. The video offers a look inside the company’s refinery, which is the only permitted cobalt refinery in North America capable of producing battery materials. The video, titled, “Get to Know the First Cobalt Refinery,” also includes comments from the company’s management team. The video is now available on the company's website at http://ibn.fm/j5OkU To view the full press release, visit http://ibn.fm/jL1Po About First Cobalt Corp. First Cobalt is a vertically integrated…

Continue Reading

ThursdayOct 11, 2018 9:52 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence…

Continue Reading

ThursdayOct 11, 2018 9:51 am

665 Energy, Inc. (SSOF) Building Momentum as Energy Industry Supplier, Resale Business

665 Energy, Inc. positioned to supply upstream, midstream and downstream clients in oil and gas industry Global market for oil industry supplies expected to grow to $205 billion by 2020 Company also advancing plans to expand into purchase, refurbish and resale of oil drilling rigs The energy industry continues to form the bedrock of life-improving technological innovation more than a century after the end of the second Industrial Revolution, propelling global economies in which rapid transportation, mass manufacture and space satellite-enabled communication combine to elevate the standard of living for people around the world. As modern clean energy proponents work…

Continue Reading

ThursdayOct 11, 2018 9:36 am

QualityStocksNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced that its investee company ezGreen Compliance has expanded its proprietary Business Intelligence Dashboard (“BID”) by adding a new comprehensive taxation feature to automate crucial revenue reporting functionality. ezGreen Compliance provides a state-of-the-art enterprise compliance and point-of-sale (“POS”) software solution for licensed medical cannabis dispensaries and cultivators. ezGreen plans to roll out the new taxation feature as a fully integrated component of its BID to the company’s affiliate network comprised of more than 200 dispensary locations. Furthermore, ezGreen’s BID, which was developed…

Continue Reading

ThursdayOct 11, 2018 9:17 am

Argentina Proving to be a Land of Opportunity for Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

Marifil Mines’ primary exploration goals involve high-demand gold, lithium and cobalt targets Argentina is the third-largest gold producer in South America and anticipates most of its geological potential has yet to be tapped Canada-based Marifil has numerous project sites throughout Argentina in search for gold, lithium, cobalt, nickel, platinum, silver, phosphate and potassium Argentina’s nascent mining industry is proving to be a land of opportunity for Canadian explorer Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF), which has projects established throughout the country and most recently has been evaluating the gold and silver prospects of its property in the country’s southeastern…

Continue Reading

WednesdayOct 10, 2018 12:45 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

Continue Reading

WednesdayOct 10, 2018 12:27 pm

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Moves Forward in Developing As-Needed Treatment for Social Anxiety Disorder

Company signs a worldwide licensing agreement with Pherin Pharmaceuticals for the development and commercialization of a Phase 3-ready CNS drug candidate for as-needed treatment of social anxiety disorder Untreated social anxiety disorder has a significant impact on a person’s overall quality of life Clinical studies support the potential of PH94B to be a superior treatment alternative for SAD due to the demonstrated rapid onset of efficacy, route of administration, as-needed dosing convenience and excellent safety profile VistaGen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and…

Continue Reading

WednesdayOct 10, 2018 12:00 pm

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC), a vertically integrated North American pure-play cobalt company, this morning announced the results of three studies supporting a restart of the First Cobalt Refinery in Ontario, Canada. Per the update, the three independent studies were undertaken to estimate the capital requirements, operating costs, permit renewal timelines, potential feedstock options and offtake opportunities presented by the refinery. The permitting review concluded that a restart is possible within 18 months of selecting a feedstock under the base case scenario. “The First Cobalt Refinery is a strategic North American asset and potentially our quickest…

Continue Reading

WednesdayOct 10, 2018 11:59 am

ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://ibn.fm/xUF36). In a news release, Warren Wang, CEO of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered